AG真人官方

Verastem, Inc. (VSTM) 鈥� Form 4 insider transaction summary

Chief Financial Officer Daniel Calkins filed a Form 4 reporting two open-market sales of Verastem common stock:

• 06/20/2025: 4,110 shares sold at $5.13 per share.
• 06/23/2025: 25 shares sold at $4.71 per share.

The filing explains that the transactions were executed solely to cover statutory tax-withholding obligations triggered by the vesting of previously granted restricted stock units (RSUs). No derivative securities were involved in this report.

Following the sales, Calkins鈥� direct beneficial ownership stands at 109,945 common shares. The disposition represents roughly 3.6 % of his previously reported direct holdings, leaving the executive with a substantial equity position that continues to align his interests with shareholders.

No additional purchases, option exercises, or new awards were disclosed, and there is no indication of a 10b5-1 trading plan for these transactions. Because the sales were relatively small and explained as tax-related, the market impact is expected to be limited; however, investors often track insider activity for sentiment cues, and any sale by a senior officer can attract attention.

Schedule 13G/A Amendment No. 1 overview: Truist Financial Corp., filing as a parent holding company for its investment-adviser subsidiary Truist Advisory Services, reports that it no longer holds any shares of the ALPS ETF Trust security with CUSIP 00162Q544. The filing is dated 6 June 2025 (event date 30 June 2025) and serves to remediate earlier ownership reports that were not submitted when the position fell below the 5 % threshold.

Key ownership details

• Aggregate beneficial ownership: 0 shares
• Percent of class: 0.0 %
• Sole or shared voting/dispositive power: 0 in all categories
• The position was fully liquidated on 22 Oct 2021, according to the footnote.

The certification confirms the shares were held in the ordinary course of business and not for the purpose of influencing control of the issuer. The signatory is Edward M. Kwiatkowski, Vice President, signing on behalf of Truist Financial Corp. on 2 July 2025.

Implications for investors: Truist鈥檚 complete exit means the ETF has lost a prior reportable institutional holder. While this change may alter the ETF鈥檚 institutional ownership profile, the lack of any current stake limits market impact. The filing mainly reflects regulatory compliance housekeeping rather than a new strategic move.

Verastem, Inc. (VSTM) Form 4 filing: On 06/16/2025, President & CEO and director Dan Paterson reported the sale of 335 shares of Verastem common stock at $5.65 per share. The transaction code 鈥淪鈥� indicates an open-market sale, but the footnote clarifies that the shares were sold solely to satisfy statutory tax-withholding obligations arising from recently vested restricted stock units (RSUs).

Following the small disposition, Paterson鈥檚 direct ownership stands at 461,647 shares. The sale represents less than 0.1 % of his post-transaction holdings, suggesting no meaningful change in his economic exposure to the company. No derivative security transactions were reported, and there were no indications of additional sales or purchases under a Rule 10b5-1 trading plan. Overall, the filing signals routine administrative activity rather than a strategic shift in insider sentiment.

SEC Form 4 overview 鈥� Verastem, Inc. (VSTM)

On 06/16/2025 director Robert E. Gagnon reported the disposition of 284 common shares at $5.65 per share, an aggregate value of roughly $1.6 thousand. The sale was executed solely to satisfy statutory tax-withholding requirements related to the vesting of restricted stock units, according to the filing鈥檚 footnote. After the transaction Gagnon directly owns 42,242 shares; no derivative securities were traded or reported. Because the sale represents less than 1% of his holdings and is administrative in nature, the filing signals minimal change in insider alignment and no operational impact on Verastem.

Royal Bank of Canada (RY) is offering $8.32 million of STEP Income Securities庐 (831,980 units, $10 principal per unit) linked to the common stock of Halliburton Company (NYSE: HAL). The senior unsecured notes mature on 6 July 2026 (term 鈮� 1 year + 2 weeks) and are subject to RBC鈥檚 credit risk. Investors will receive quarterly interest of 15.25 % p.a. (鈮� 3.8125 % per quarter). At maturity an additional Step Payment of $0.306 per unit (3.06 %) is paid only if HAL鈥檚 closing price on the valuation date (26 June 2026) is 鈮� $26.52 (115.25 % of the $23.01 Starting Value).

If HAL鈥檚 Ending Value is below the $23.01 Threshold Value, principal is reduced 1-for-1; there is no downside protection. All payments are unsecured, not FDIC/CDIC insured and rely on RBC鈥檚 ability to pay. The public offering price of $10 exceeds the initial estimated value of $9.74, reflecting a $0.15 underwriting discount and a $0.05 hedging-related charge. No exchange listing is planned and secondary-market liquidity is expected to be limited; BofA Securities acts as calculation agent.

Key risks disclosed include potential loss of principal, limited upside (interest + Step Payment cap), market value likely below issue price before maturity, tax uncertainty for U.S. and non-U.S. holders, and multiple conflicts of interest in hedging and calculation. The notes are intended for investors seeking high periodic income, willing to accept HAL equity risk, full principal-at-risk, and limited liquidity.